Sibrafiban. Platelet antiaggregatory fibrinogen gpIIb/IIIa receptor antagonist

Drugs of the Future

Volumn 23, Issue 12, 1998, Pages 1297-1303

  Merlos, M ^a   Graul, A ^a   Castaner, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; SIBRAFIBAN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONFORMATION; DRUG EFFECT; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0032431146     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.12.474031     Document Type: Article

References (34)